NANOG and hepatocellular carcinoma: Activated classical IL-6/STAT3 signaling is commonly related to HCC developed from liver injury and inflammation [34] and induces OCT4/NANOG expression to confer poor prognosis of HBV-related hepatocellular carcinoma [35].